update - US FDA confirms lifting of import alert
Sun says US FDA poised to lift Mohali import alert
Sun Pharmaceutical Industries Ltd has said the US FDA plans to lift the import alert imposed on its manufacturing plant in Mohali, Punjab in India.
Archives for March 14, 2017
Cytel: model-informed drug development expanding area of focus
Cytel Inc. has established a dedicated quantitative pharmacology and pharmacometrics team to meet an increasing demand for model-informed drug development from biopharma clients.
FDA commissioner nominee would be a 'strong partner,' says ACRO
Last week, President Donald Trump announced Scott Gottlieb as his nomination for the new US FDA commissioner – a candidate that ACRO says, “understands the complexities of drug development.”
Siegfried’s revenues up on APIs and new plants, earnings down on costs
Siegfried saw higher sales in 2016 thanks to the API business it bought from BASF and opening of new plant in China, but profits fell on integration costs and higher taxes.